Rare disease research is vital to improve ... By minimising the exposure to ineffective therapies, RAR trial designs improve recruitment and retention rates, and are an efficient use of limited ...

In a first-of-its-kind clinical study, scientists at The University of Texas at Dallas and Baylor University Medical Center ...

Record prices might be fixing attention on gold miners, but eagle-eyed analysts and investors are looking to a breakout from ...

Silence heals the brain and nervous system naturally by reducing stress, restoring sleep, and enhancing cognitive performance ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...

The Lost Generator blueprint reveals a DIY Edison-inspired method for generating home electricity without solar panels or the ...

About an hour after CEO Brian Chesky unveiled the new Airbnb app to the world, Teo Connor, the company’s VP of design, takes a moment to reflect on the 18-month project. It’s a key move for ...

Keep it simple: T-bills offer a robust defense against today’s radical uncertainty. When conditions normalize—when term ...

In a Phase 2a study in patients with MELAS, zagociguat exhibited a favorable safety profile, exposure throughout the body including in the central nervous system, and improvements in neuronal function ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Hannah Smith speaks to investors about the increasing infrastructure opportunities in AI, renewable energy and utilities ...

Interim data from ENERGY 3 trial highlight INZ-701's potential to modify disease course in ENPP1 Deficiency, with sustained ...